Business Context and Reporting Period
This Form 6-K filing by InflaRx N.V. reports the results of the Annual General Meeting of Shareholders held on May 17, 2018. The filing date is May 18, 2018. The company is a foreign private issuer headquartered in Jena, Germany.
Key Financial Metrics
The filing text does not provide specific financial values for revenue, profit, cash flow, margins, debt, or liquidity. The document confirms that shareholders approved the adoption of the Dutch statutory annual accounts for the fiscal year ended December 31, 2017, but does not disclose the numerical contents of those accounts.
Material Changes
No material financial changes or operational updates are detailed in this specific filing. The document focuses exclusively on corporate governance actions approved by shareholders.
Guidance, Outlook, and Corporate Actions
Shareholders approved the following agenda items:
- Adoption of Accounts: Approval of the Dutch statutory annual accounts for the fiscal year ended December 31, 2017.
- Director Liability: Release from liability for directors regarding their performance during the fiscal year ended December 31, 2017.
- Share Issuance: Extension of authorization for the Board to issue shares and grant rights to subscribe for shares.
- Pre-emption Rights: Extension of authorization for the Board to limit and exclude pre-emption rights.
- Share Repurchase: Extension of authorization for the Board to acquire shares and depository receipts for shares in the company's capital.
The filing contains no management commentary on future guidance, risks, or contingencies.
Investor Verification Checklist
- Verify the specific financial figures in the Dutch statutory annual accounts for the fiscal year ended December 31, 2017, which were approved but not detailed in this filing.
- Review the company's 20-F annual report for comprehensive financial data and risk factors.
- Monitor future filings for details on the execution of the newly authorized share issuance and repurchase programs.